Stephen Richard - 20 Jun 2025 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
Director
Signature
/s/ Stephen Richard
Issuer symbol
ANIK
Transactions as of
20 Jun 2025
Net transactions value
$0
Form type
4
Filing time
24 Jun 2025, 17:13:40 UTC
Previous filing
11 Jul 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Richard Stephen Director 32 WIGGINS AVENUE, BEDFORD /s/ Stephen Richard 24 Jun 2025 0001823843

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Award $0 +14,164 +42% $0.000000 47,871 20 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026.